ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1922

Association of Leukocyte Populations in Peripheral Blood and Arterial Wall Inflammation Assessed by FDG-PET in Takayasu’s Arteritis and Giant Cell Arteritis

K. Bates Gribbons1, Kaitlin Quinn2, Mark Ahlman3, Peter Merkel4 and Peter C. Grayson5, 1McGovern Medical School UT Houston, Houston, TX, 2Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, 3National Institutes of Health, Clinical Center, Radiology and Imaging Sciences, Bethesda, MD, 4University of Pennsylvania, Philadelphia, PA, 5Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD

Meeting: ACR Convergence 2020

Keywords: Biomarkers, giant cell arteritis, Imaging, Takayasu.s arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Positron emission tomography (PET) is useful to demonstrate fluorodeoxyglucose (FDG) uptake in the large arteries in both Takayasu’s arteritis (TAK) and giant cell arteritis (GCA). Delayed FDG-PET imaging at 2 hours rather than 1 hour after FDG injection has greater sensitivity to detect vascular wall inflammation as measured by FDG uptake.  The specific cell populations responsible for FDG uptake within the large arteries are not well defined. The objective of this study was to assess whether vascular PET activity is associated with specific leukocyte subsets in peripheral blood at 1- and 2-hour post-FDG injection timepoints in patients with TAK and GCA.

Methods: Patients with TAK and GCA were recruited into a prospective, observational cohort.  All patients received PET imaging 2 hours after FDG injection, and a random subset of these patients had additional PET imaging 1 hour after FDG injection.  PETVAS, a qualitative summary score of arterial uptake in 9 arterial territories, was used to quantify vascular PET activity.  Absolute neutrophil, monocyte, and lymphocyte counts were determined by complete blood counts.  CD8+ and CD4+ T lymphocytes, and CD19+ B lymphocytes were quantified by flow cytometry.  CRP and ESR were measured.  All laboratory tests were performed within 24 hours of PET imaging.  Mixed model linear regression was used to identify associations between PETVAS and leukocyte populations, ESR, and CRP at both timepoints, adjusting for daily prednisone dose.

Results: 91 patients (TAK = 38, GCA = 53) contributed 201 visits for the 2-hour imaging timepoint.  A subset of 75 patients (TAK = 31, GCA = 44) contributed 158 visits for the 1-hour imaging timepoint.  Baseline characteristics were as follows: female gender (TAK: 79%, GCA: 75%), average age (TAK: 36.1±11 years, GCA: 70±8 years), average prednisone dose (TAK: 3.8±6 mg/day, GCA: 14.3±19 mg/day), ESR (TAK: 20.8±11 mm/hr, GCA: 25.3±24 mm/hr), and CRP (TAK: 10.6±12 mg/L, GCA: 10.2±21 mg/L).

At the 2-hour time point, PET activity was associated with absolute monocyte count in TAK (β estimate: 1.47, 95%CI: 1.04-2.08) and GCA (β estimate: 1.20, 95%CI: 1.02-1.42).  PET activity at the 2-hour timepoint was not associated with other leukocyte populations.  At the 1-hour timepoint, CD8+ T lymphocyte count was weakly associated with PET activity in patients with TAK (β estimate: 1+4.6e-4, 95%CI: 1+3.1e-6 – 1+9.0e-4) but not in patients with GCA (β estimate: 1.00, 95%CI: 0.99-1.02).  Other leukocyte populations, including absolute monocyte count, were not associated with PET activity at the 1-hour timepoint.  There was no association between CRP or ESR with PET activity in TAK or GCA at either timepoint.

Conclusion: In both TAK and GCA, delayed FDG-PET imaging is associated with a patient’s absolute monocyte count.  The monocyte/macrophage lineage likely contributes to FDG uptake in large-vessel vasculitis and could be an important cell population to target therapeutically in these diseases.  Circulating biomarkers related to monocytes may constitute novel biomarkers for vascular PET activity.  Future studies that compare circulating biomarkers to vascular PET activity should employ delayed imaging approaches.


Disclosure: K. Gribbons, None; K. Quinn, None; M. Ahlman, None; P. Merkel, AbbVie, 5, Biogen, 5, Celgene, 2, 5, ChemoCentryx, 2, 5, CSL Behring, 5, Forbius, 2, 5, Genentech/Roche, 2, 5, Genzyme/Sanofi, 2, 5, GlaxoSmithKline, 2, 5, InflaRx, 2, 5, Insmed, 5, Jannsen, 5, Kiniksa, 5, Magenta, 5, Novartis, 5, Pfizer, 5, Sparrow, 5, Talaris, 5, AstraZeneca, 2, 5, Boeringher-Ingelheim, 2, 5, Bristol-Myers Squibb, 2, 5, UpToDate, 7; P. Grayson, None.

To cite this abstract in AMA style:

Gribbons K, Quinn K, Ahlman M, Merkel P, Grayson P. Association of Leukocyte Populations in Peripheral Blood and Arterial Wall Inflammation Assessed by FDG-PET in Takayasu’s Arteritis and Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/association-of-leukocyte-populations-in-peripheral-blood-and-arterial-wall-inflammation-assessed-by-fdg-pet-in-takayasus-arteritis-and-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-leukocyte-populations-in-peripheral-blood-and-arterial-wall-inflammation-assessed-by-fdg-pet-in-takayasus-arteritis-and-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology